What antibiotic should be started in a 13-year-old patient with enteric fever, perforated abdomen, and severe sepsis with septic shock and acute kidney injury (AKI) post-exploratory laparotomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Management for Severe Sepsis with Septic Shock in a 13-Year-Old with Enteric Fever and Perforated Abdomen

For this 13-year-old patient with enteric fever, perforated abdomen, post-operative septic shock and AKI, immediate broad-spectrum antibiotic therapy should include meropenem as the first-line agent at a dose adjusted for renal function.

Initial Antibiotic Selection

  • Antimicrobial therapy must be initiated as soon as possible and within one hour of sepsis recognition, as each hour of delay increases mortality risk 1
  • For severe sepsis/septic shock with intra-abdominal source, broad-spectrum coverage is essential to target all likely pathogens including gram-negative, gram-positive, and anaerobic bacteria 1
  • The initial selection should consider:
    • Patient factors (age, weight, renal function) 1
    • Likely pathogens (enteric fever typically caused by Salmonella typhi/paratyphi) 1
    • Local resistance patterns 1
    • Severity of illness (septic shock) 1

Recommended Antibiotic Regimen

  • First-line recommendation: Meropenem monotherapy at a renally adjusted dose 1, 2

    • Meropenem provides excellent coverage against enteric pathogens including Salmonella species, gram-negative bacteria, and anaerobes 2
    • For a 40 kg patient with AKI, dosing should be adjusted based on estimated renal function 2
    • Initial loading dose should be full (20 mg/kg), followed by maintenance doses adjusted for renal impairment 2
  • Alternative regimen: If meropenem is unavailable, combination therapy with:

    • Extended-spectrum beta-lactam (piperacillin-tazobactam or cefepime) plus metronidazole 1
    • Consider adding an aminoglycoside (gentamicin) as a single dose for synergistic effect 3, 4

Dosing Considerations with AKI

  • Despite AKI, administer a full loading dose of antibiotics to ensure adequate initial blood levels 1
  • For meropenem maintenance dosing in AKI:
    • Estimate creatinine clearance and adjust interval or dose accordingly 2
    • Monitor drug levels when available 1
  • If gentamicin is used, a single dose (5 mg/kg) appears safe even in patients with sepsis and does not significantly increase AKI risk 5, 4

Reassessment and De-escalation

  • Reassess antibiotic therapy within 24-48 hours based on culture results and clinical response 1
  • De-escalate to more targeted therapy once the causative pathogen and susceptibilities are identified 1
  • Continue appropriate antibiotics for 7-10 days depending on clinical response 1, 6

Special Considerations

  • Ensure adequate source control has been achieved with the exploratory laparotomy 1
  • Monitor renal function closely and adjust antibiotic dosing as needed 1, 2
  • Consider procalcitonin levels to guide duration of antibiotic therapy if available 1

Common Pitfalls to Avoid

  • Delaying antibiotic administration beyond one hour significantly increases mortality 6, 7
  • Using inadequate dosing due to concerns about renal function - always give full loading doses 1
  • Failing to reassess and de-escalate therapy, which can promote resistance 1
  • Neglecting to adjust maintenance doses based on changing renal function 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute kidney injury and single-dose administration of aminoglycoside in the Emergency Department: a comparison through propensity score matching.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2021

Guideline

Management of Sepsis Secondary to BSI, UTI, and Pancolitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Empiric Antibiotics for Sepsis.

Surgical infections, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.